Seeing Is Believing
RNA is currently covered by 8 analysts with an average price target of $82.2. This is a potential upside of $32.43 (65.16%) from yesterday's end of day stock price of $49.77.
Avidity Biosciences 's activity chart (see below) currently has 62 price targets and 75 ratings on display. The stock rating distribution of RNA is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 41.58% with an average time for these price targets to be met of 298 days.
Highest price target for RNA is $96, Lowest price target is $65, average price target is $72.38.
Most recent stock forecast was given by JOSH SCHIMMER from EVERCORE on 22-Sep-2025. First documented stock forecast 07-Jul-2020.
Currently out of the existing stock ratings of RNA, 27 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
$65
$18 (38.30%)
$53
18 days ago
(22-Sep-2025)
4/7 (57.14%)
$22.66 (53.52%)
448
Buy
$65
$18 (38.30%)
$75
25 days ago
(15-Sep-2025)
4/7 (57.14%)
$24.78 (61.61%)
75
Buy
$75
$28 (59.57%)
$75
1 months ago
(10-Sep-2025)
8/15 (53.33%)
$28.6 (61.64%)
299
Buy
$65
$18 (38.30%)
$60
1 months ago
(10-Sep-2025)
11/17 (64.71%)
$18.6 (40.09%)
246
Buy
$96
$49 (104.26%)
$96
3 months 13 days ago
(27-Jun-2025)
0/3 (0%)
$66.97 (230.69%)
What is RNA (Avidity Biosciences ) average time for price targets to be met?
Which analyst has the current highest performing score on RNA (Avidity Biosciences ) with a proven track record?
Which analyst has the most public recommendations on RNA (Avidity Biosciences )?
Which analyst is the currently most bullish on RNA (Avidity Biosciences )?
Which analyst is the currently most reserved on RNA (Avidity Biosciences )?